The clinic that doesn't close at five
It is a Tuesday at 11:47 p.m. and somewhere in central Ohio, a 34-year-old who has been quietly drafting a goodbye note opens an app instead. Within hours she has a clinician on a video call. Within seventy-two she has a treatment plan that includes both a medication change and a CAMS-trained therapist. She is, statistically speaking, very likely to be alive in twelve weeks - and not just alive, but measurably better.
This is what Brightside Health does for a living. Not slogans. Not wellness gummies. Care for the part of the mental-health spectrum that scares most platforms off.
The problem they saw
The American mental-health system is famously broken in the kind of way nobody bothers calling broken anymore. The average wait for a new psychiatry appointment in many U.S. cities still measures in months. Roughly half of U.S. counties have no practicing psychiatrist at all. And the patients with the highest acuity - those with suicidal ideation, severe depression, co-occurring substance use - are routinely told that they are, in clinical parlance, "not appropriate" for telehealth.
Brightside's three co-founders looked at that sentence and noticed it was doing a lot of work. Not appropriate for whom? The platforms, mostly. The technology, occasionally. Rarely the patients themselves.
The market gap, in one paragraph
Anxiety and depression affect more than 50 million American adults. Roughly two-thirds never receive adequate treatment. Of those who do, fewer than half reach remission on their first medication trial. A 30-year-old industry has met this problem largely with longer waitlists.
File photo: the American mental-health system, drawn to scale.
The founders' bet
Brad Kittredge had spent a decade building consumer health products at 23andMe and Lantern. He had also, less publicly, spent years watching a close family member navigate lifelong depression. The two facts were not unrelated. He believed - in the patient, methodical way of someone who has read too many EHR screens - that mental-health care could be both consumer-grade and clinically serious. Most people thought you had to pick.
Mimi Winsberg, MD, was the clinician who agreed with him. A Stanford-trained psychiatrist with 25 years of practice and a stint as the on-site psychiatrist at the Facebook wellness center, she had spent enough time inside Silicon Valley to know what tech-enabled care looked like when it worked, and what it looked like when it merely shipped. Jeremy Barth, the technical co-founder, joined to make sure the second possibility didn't happen.
Their bet was unfashionable at the time. While the rest of the digital-health cohort was racing toward subclinical anxiety and direct-to-consumer Adderall, Brightside started with the harder cases. The unit economics were worse. The clinical risk was higher. The defensibility, they suspected, would be considerably better.
The product, minus the marketing
Psychiatry
Virtual evaluations and ongoing medication management, guided by a proprietary precision-prescribing model. It analyzes more than 100 patient variables to suggest a first-line medication a clinician is more likely to keep.
Therapy
1:1 video sessions with licensed providers, anchored in cognitive behavioral therapy. Between visits, patients work through self-guided lessons and message their clinician - quietly, without the small theater of a phone call.
Crisis Care
The first nationally available telehealth program built for adults at elevated suicide risk, based on the CAMS framework. Appointments inside 24-72 hours. The program many platforms quietly route around.
Substance Use Disorder
Virtual Intensive Outpatient Treatment for co-occurring substance use, launched in June 2024. The clinical scope keeps widening; the business model keeps narrowing onto serious care.
Pictured above: four products that, collectively, decline to be called wellness.
Milestones / a short history of stubbornness
Brightside Health founded in San Francisco by Brad Kittredge, Mimi Winsberg, MD and Jeremy Barth.
Seed round closes; first patients see psychiatrists on the platform.
$24M Series A. National expansion accelerates across all 50 states.
$50M Series B led by ACME and S32. Crisis Care announced - the first nationwide telehealth program for elevated suicide risk.
Peer-reviewed Crisis Care effectiveness data published. Medicare and Medicaid coverage expands.
$33M Series C in March. Substance Use Disorder and virtual IOP launched in June.
Live across all 50 states. ~400 employees. $114M raised to date.
The proof, with receipts
It is one thing to claim outcomes. It is another to publish them. Brightside has done the second thing - which, in a category long defined by the first, counts as a competitive moat.
Outcomes at 12 weeks
Chart with numbers attached. Health-tech, please borrow.
The payer side has noticed. Brightside is in-network with Aetna, Cigna, Optum/United, Anthem and a long list of Blue Cross plans, plus Medicare and a growing list of state Medicaid programs. HSA and FSA cards work. For a category that spent five years on cash-pay subscriptions, this is a deeply unsexy and deeply important achievement.
The mission, restated
Brightside's mission - "life-changing mental health care to everyone who needs it" - reads, on first encounter, like every other deck in the category. The difference shows up in the qualifier. Everyone includes people with severe and persistent illness. It includes patients on Medicaid. It includes the person whose risk score makes most platforms route to a 1-800 number and a hopeful goodbye.
That is the mission expressed in product decisions, not slide decks. Crisis Care exists because the team decided that the highest-risk patients were exactly the ones a national virtual clinic should be best at reaching. The substance-use program exists because the same patients keep showing up with overlapping conditions. The precision-prescribing model exists because if you are going to take harder cases, you had better get the first medication right more often than chance.
Coverage, in plain English
50 states. Major commercial insurers. Medicare. Medicaid in a growing list of markets. Cash-pay still available. HSA/FSA accepted. No-shows tolerated. Self-guided lessons included.
Why it matters tomorrow
The next decade of mental-health care will not be decided by who has the best meditation library. It will be decided by who can take the hardest patients, prove they get better, and convince payers to pay for it. That is a three-part problem. Most companies have solved one. A few have solved two. Brightside is one of the very small group attempting all three at the same time.
AI will help - in fact, it already is. Brightside's machine-learning models inform medication selection, surface suicide-risk signals to clinicians, and help personalize therapy modules. None of this is marketing. The papers are on PubMed. The dashboards are in Retool. The data is in BigQuery. The clinicians are in 50 states.
Back to that Tuesday night in central Ohio. The goodbye note never got finished. Twelve weeks later the patient is on a different medication, in CAMS-based therapy with a clinician she has actually grown to like, and her PHQ-9 score has dropped by more than half. She is not a slogan. She is a row in a dataset that Brightside Health intends to keep adding to, one patient at a time, until the math of American mental health looks substantially different than it does today.